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This is the second and expanded edition of The Joint
Vascular Research Group effort ‘‘The Evidence for
Vascular Surgery’’ published the first time eight years
ago. Characteristic to a multi-author book a personal
touch of each author are still recognizable as noticed
by M. Armon in his comments on the first edition in
EJVES 2000; 12: 217e218.
John Murie highlights the nature of surgical evi-
dence and evidence based practice in the elegant first
chapter. Evidence is grounds for belief in something,
he states and admits that surgery has not always
followed an evidential path. Indeed, the influence of
trend setters, i.e. eminence based practice, is often
greater than that of other modes of education. Emi-
nence based decision making may give best possible
outcomes but be the worst scenario when not based
on evidence.
Yet, not all evidence is of equal value and there are
not only one, but many attempts to build up eviden-
tial hierarchy to illustrate the strengths and weaknes-
sess of propositions. One of those are systematically
used throughout the book to allow the reader to eval-
uate the clinical data. That hierarchy is commonly used
but rather liberal. One single randomised study may
have too much impact. Also, despite whatever evi-
dence the reader has always to consider the generaliz-
ability of the presented data. Indeed, randomised
clinical trials, the proof for level 1 evidence, are to be
used only to determine, whether, on a balance of scien-
tific probability, there is a difference or the difference is
lacking in outcome of treatments with broadly similar
outcome. The RCT’s are only to identify marginal out-
come differences.
Assessment of scientific information has improved
considerably after the publication of the first edition.
Wider formal search strategies to ensure competent
search, with clear explanations what has been included
and what excluded, are used in this second edition. Yet,
there is apparent positive bias. Although gross fabrica-
tion of data is rare, problems may arise from data mis-
management, ever-increasing influential presence of
1078–5884/000124 + 02 $32.00/0  2007 Published by Elsevier Ltd.industry as a silent partner as well as unpublished neg-
ative results.
Indications for carotid endartectomy are presented
clearly. Yet the key points stating that there is no
advantage from surgery over best medical therapy in
patients with symptomatic carotid stenosis <70% can
be argued in the light of the results from the NASCET
50e69% stenosis group. Controversies around carotid
angioplasty are updated beautifully.
The role of supervised exercise programmes have
been emphasised soon 30 years, and indeed there is
significant improvement on treadmill walking dis-
tances in the groups included. The problem, of course,
is whether these results can be generalized for all
claudicants.
Use of endovascular techniques for infrainguinal
revascularisations is increasing. Yet, there is only
one study to show that balloon angioplasty has
equally good short term outcome as bypass surgery.
It also has a lower early morbidity rate, though
higher need for reoperations. An A level recommen-
dation is considered appropriate in the book, though
the generalizability of the results of the BASIL trial
are low.
Management of critical ischaemia and prevention
of amputation in a potentially ambulant patient is
an unsettled issue. Wisely, the authors pinpoint that
the old European Consensus Document recommenda-
tion that ‘‘a reconstructive procedure should be at-
tempted if there is a 25% chance of saving the useful
limb for a patient at least one year’’ is not evidence
based. Yet they do not give any data to support their
own recommendation that reconstruction requires
a success rate of 75% at one year to become
cost-effective.
The chapter of nonsurgical treatment of critical
leg ischaemia is practically the same as in the pre-
vious edition with only 3 out of 25 references from
this millennium when those on gene and stem cell
therapy were excluded. Key points with only 1a
evidence and level A recommendations easily mis-
lead the reader to overestimate the value of these
methods.
As to the aneurysm screening the chapter
emphasises the decrease in aneurysm related mortality
of 42e66% obtained by screening. Cost-effectiveness
125Book Reviewof screening was underlined as well. Counter evidence
has been deemed inappropriate and not accepted.
The questions remains, screening is worthwhile, but
for whom and where. Simplified answer that clinical
benefits of screening 65-year old men for AAA are
proven beyond reasonable doubt (1a/A) may be
criticised.
New diagnostic and interventional techniques for
varicose veins are presented in three chapters, all of
which illustrate the paucity of comparative evidence
on these methods.All in all, this book is easy to read and contains a lot
of useful information in a well-set form with good pic-
tures and highlighted key points for the hasty reader.
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